Risk predictors in patients with diabetic nephropathy.

P. Fioretto, M. L. Caramori, M. Dalla Vestra, M. Mauer

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Diabetic nephropathy is currently the most common cause of end-stage renal disease in the Western countries. Only approximately one third of patients with type 1 diabetes develop nephropathy; thus, because it is not feasible to aggressively treat all patients, it becomes very important to find early markers in order to identify patients at high nephropathy risk. To date the best available predictor of overt nephropathy is microalbuminuria. In this article we review the validity of microalbuminuria as a predictor of overt nephropathy and consider other markers of nephropathy risk.

Original languageEnglish (US)
Pages (from-to)245-250
Number of pages6
JournalCurrent Diabetes Reports
Volume1
Issue number3
DOIs
StatePublished - Jan 1 2001

Fingerprint

Diabetic Nephropathies
Type 1 Diabetes Mellitus
Chronic Kidney Failure

Cite this

Risk predictors in patients with diabetic nephropathy. / Fioretto, P.; Caramori, M. L.; Dalla Vestra, M.; Mauer, M.

In: Current Diabetes Reports, Vol. 1, No. 3, 01.01.2001, p. 245-250.

Research output: Contribution to journalReview article

Fioretto, P. ; Caramori, M. L. ; Dalla Vestra, M. ; Mauer, M. / Risk predictors in patients with diabetic nephropathy. In: Current Diabetes Reports. 2001 ; Vol. 1, No. 3. pp. 245-250.
@article{7a1be612c0ea49e8b051c32bf163925f,
title = "Risk predictors in patients with diabetic nephropathy.",
abstract = "Diabetic nephropathy is currently the most common cause of end-stage renal disease in the Western countries. Only approximately one third of patients with type 1 diabetes develop nephropathy; thus, because it is not feasible to aggressively treat all patients, it becomes very important to find early markers in order to identify patients at high nephropathy risk. To date the best available predictor of overt nephropathy is microalbuminuria. In this article we review the validity of microalbuminuria as a predictor of overt nephropathy and consider other markers of nephropathy risk.",
author = "P. Fioretto and Caramori, {M. L.} and {Dalla Vestra}, M. and M. Mauer",
year = "2001",
month = "1",
day = "1",
doi = "10.1007/s11892-001-0042-6",
language = "English (US)",
volume = "1",
pages = "245--250",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Risk predictors in patients with diabetic nephropathy.

AU - Fioretto, P.

AU - Caramori, M. L.

AU - Dalla Vestra, M.

AU - Mauer, M.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Diabetic nephropathy is currently the most common cause of end-stage renal disease in the Western countries. Only approximately one third of patients with type 1 diabetes develop nephropathy; thus, because it is not feasible to aggressively treat all patients, it becomes very important to find early markers in order to identify patients at high nephropathy risk. To date the best available predictor of overt nephropathy is microalbuminuria. In this article we review the validity of microalbuminuria as a predictor of overt nephropathy and consider other markers of nephropathy risk.

AB - Diabetic nephropathy is currently the most common cause of end-stage renal disease in the Western countries. Only approximately one third of patients with type 1 diabetes develop nephropathy; thus, because it is not feasible to aggressively treat all patients, it becomes very important to find early markers in order to identify patients at high nephropathy risk. To date the best available predictor of overt nephropathy is microalbuminuria. In this article we review the validity of microalbuminuria as a predictor of overt nephropathy and consider other markers of nephropathy risk.

UR - http://www.scopus.com/inward/record.url?scp=0035790317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035790317&partnerID=8YFLogxK

U2 - 10.1007/s11892-001-0042-6

DO - 10.1007/s11892-001-0042-6

M3 - Review article

VL - 1

SP - 245

EP - 250

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 3

ER -